Specialty medicines

High-complexity products with cold chain, handling, or distribution constraints beyond standard formularies.

• Abatacept

  Abatacept: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab

  Adalimumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab Adaz

  Adalimumab Adaz: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab Adbm

  Adalimumab Adbm: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab Afzb

  Adalimumab Afzb: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab Bwwd

  Adalimumab Bwwd: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Adalimumab Fkjp

  Adalimumab Fkjp: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Alirocumab

  Alirocumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Anifrolumab Fnia

  Anifrolumab Fnia: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Ansuvimab

  Ansuvimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Atezolizumab

  Atezolizumab: structured procurement-oriented summary for hospital and wholesale readers. Not medical advice; availability depends on region and authorization.
• Atoltivimab Maftivimab Odesivimab

  Atoltivimab Maftivimab Odesivimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Atoltivimab Maftivimab Odesivimab Ebgn

  Atoltivimab Maftivimab Odesivimab Ebgn: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Avelumab

  Avelumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Azathioprine

  Azathioprine: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Azathioprine Sodium

  Azathioprine Sodium: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Basiliximab

  Basiliximab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Belantamab Mafodotin

  Belantamab Mafodotin: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Bevacizumab

  Bevacizumab: structured procurement-oriented summary for hospital and wholesale readers. Not medical advice; availability depends on region and authorization.
• Bevacizumab Bvzr

  Bevacizumab Bvzr: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Bevacizumab Nwgd

  Bevacizumab Nwgd: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Blinatumomab

  Blinatumomab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Brentuximab Vedotin

  Brentuximab Vedotin: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Brodalumab

  Brodalumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Cemiplimab

  Cemiplimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Cemiplimab Rwlc

  Cemiplimab Rwlc: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Certolizumab Pegol

  Certolizumab Pegol: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Cetuximab

  Cetuximab: structured procurement-oriented summary for hospital and wholesale readers. Not medical advice; availability depends on region and authorization.
• Clesrovimab

  Clesrovimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Cosibelimab

  Cosibelimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Crizanlizumab

  Crizanlizumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Cyclosporine

  Cyclosporine: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Daratumumab

  Daratumumab: structured procurement-oriented summary for hospital and wholesale readers. Not medical advice; availability depends on region and authorization.
• Dinutuximab

  Dinutuximab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Dostarlimab

  Dostarlimab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Durvalumab

  Durvalumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Elotuzumab

  Elotuzumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Elranatamab Bcmm

  Elranatamab Bcmm: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Enfortumab Vedotin

  Enfortumab Vedotin: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Etanercept

  Etanercept: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Everolimus

  Everolimus: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Evinacumab

  Evinacumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Glofitamab

  Glofitamab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Golimumab

  Golimumab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Ibritumomab Tiuxetan

  Ibritumomab Tiuxetan: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Infliximab

  Infliximab: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Infliximab Dyyb

  Infliximab Dyyb: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.
• Linvoseltamab Gcpt

  Linvoseltamab Gcpt: structured procurement-oriented summary for hospital, clinic, and pharmacy sourcing teams. Not medical advice; availability depends on region and authorization.